Description

Butanamide, n-(6-Amino-1,2,3,4-tetrahydro-3-methyl-2,4-dioxo-1-phenyl-5-pyrimidinyl)-4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]- is a high-purity, complex heterocyclic organic compound that serves as a critical advanced intermediate in pharmaceutical research and development. Its unique molecular architecture, combining pyrimidine and coumarin moieties, makes it a valuable building block for synthesizing novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. This compound is essential for R&D chemists and process development scientists in the pharmaceutical and biotechnology sectors, particularly those focused on developing new drug candidates in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, particularly those targeting specific enzyme pathways.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and the creation of focused compound libraries.
• API Synthesis: Serves as a sophisticated building block in the development and scale-up of new Active Pharmaceutical Ingredients (APIs).
• Biochemical Research: Employed as a probe or inhibitor in biochemical assays to study biological mechanisms involving heterocyclic recognition.
• Contract Manufacturing (CMO): Supplied to contract research and manufacturing organizations (CROs/CMOs) for custom synthesis projects.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and methodological studies.

Basic Information

Product Name	Butanamide, n-(6-Amino-1,2,3,4-tetrahydro-3-methyl-2,4-dioxo-1-phenyl-5-pyrimidinyl)-4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-
CAS No.	301206-08-6
Molecular Formula	C24H22N4O5
Molecular Weight	446.46 g/mol
Synonyms	4-[(2-Oxo-2H-chromen-7-yl)oxy]-N-[6-amino-3-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydro-5-pyrimidinyl]butyramide; 7-({4-[(6-Amino-3-methyl-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydro-5-pyrimidinyl)amino]-4-oxobutyl}oxy)-2H-1-benzopyran-2-one; CAS 301206-08-6; Advanced Pyrimidine-Coumarin Hybrid Intermediate; Pharmaceutical Building Block 301206-08-6.
EINECS	Contact for details

Quality Control

Our Butanamide, n-(6-Amino-1,2,3,4-tetrahydro-3-methyl-2,4-dioxo-1-phenyl-5-pyrimidinyl)-4-[(2-oxo-2H-1-benzopyran-7-yl)oxy]- is manufactured under a strict quality management system. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with each shipment to guarantee traceability and consistency for your critical research applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept sealed in a dry environment and opened under controlled conditions to minimize exposure to atmospheric moisture and light.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.